Page last updated: 2024-11-05

lawsone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Lawsone, also known as 2-hydroxy-1,4-naphthoquinone, is a natural orange-red pigment found in the henna plant (Lawsonia inermis). It is responsible for the characteristic reddish-brown color of henna tattoos and hair dyes. Lawsone is synthesized by the plant through a complex series of enzymatic reactions involving the shikimate pathway and polyketide biosynthesis. The compound exhibits a wide range of biological activities, including antioxidant, anti-inflammatory, antibacterial, and antifungal properties. It is also known to have cytotoxic effects on cancer cells. The importance of lawsone lies in its long history of use as a natural dye and medicine. It is studied extensively for its potential therapeutic applications, particularly in dermatology, wound healing, and cancer treatment. Researchers investigate its mechanisms of action, optimize its extraction and purification methods, and explore its safety and efficacy in various applications.'

lawsone: a molluscacide from leaves of Lawsonia inermis L. topical sunscreening agent; structure; powdered leaves of Lawsonia inermis(Lythraceae) used as brown hair dye [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

lawsone : 1,4-Naphthoquinone carrying a hydroxy function at C-2. It is obtained from the leaves of Lawsonia inermis. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Lawsoniagenus[no description available]LythraceaeThe loosestrife plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. Members are mainly herbs and many of them contain ALKALOIDS.[MeSH]
Lawsonia inermisspecies[no description available]LythraceaeThe loosestrife plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. Members are mainly herbs and many of them contain ALKALOIDS.[MeSH]
Hennagenus[no description available]LythraceaeThe loosestrife plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. Members are mainly herbs and many of them contain ALKALOIDS.[MeSH]

Cross-References

ID SourceID
PubMed CID6755
CHEMBL ID240963
CHEBI ID44401
SCHEMBL ID342409
SCHEMBL ID16541
MeSH IDM0046416

Synonyms (105)

Synonym
nsc-52500
4-hydroxynaphthalene-1,2-dione
UPCMLD0ENAT5883810:001
2-hydroxy-naphthalene-1,4-dione
henna
2-hydroxynaphthoquinone
c.i. natural orange 6
hana
c.i. 75480
2-hydroxy-1,4-naphthoquinone
nsc-8625
lawson
mehendi
1, 2-hydroxy-
nsc8625
mendi
1,4-naphthoquinone, 2-hydroxy-
1,4-naphthalenedione, 2-hydroxy-
nsc-27285
nsc27285
DIVK1C_006578
KBIO1_001522
SDCCGMLS-0066674.P001
SPECTRUM4_001697
SPECTRUM_001200
SPECTRUM5_000374
einecs 201-496-3
ccris 6248
nsc 8625
henna leaves
2-hydroxy-1,4-napthoquinone
ai3-12099
brn 1565260
nsc 27285
lawsonia alba
83-72-7
lawsone
nq-6
2-hydroxynaphthalene-1,4-dione
2-hydroxy-1,4-naphthoquinone, 97%
2-hydroxy-1,4-naphthalenedione
CHEBI:44401 ,
DB04744
BSPBIO_002956
NCGC00095834-01
KBIO2_001680
KBIOSS_001680
KBIO2_004248
KBIOGR_001994
KBIO3_002456
KBIO2_006816
SPBIO_001551
SPECTRUM3_001538
SPECPLUS_000482
SPECTRUM2_001506
SPECTRUM1502250
NCGC00095834-02
NCGC00095834-03
2-hydroxy-1,4-dihydronaphthalene-1,4-dione
CHEMBL240963
natural orange 6
H0285
STK801825
AKOS000120111
3,4-dioxonaphthalen-1-olate
A840637
2-hydroxy-1,4-naphoquinone
S3858
2-hydroxy-p-naphthoquinone
CCG-38882
hennotannic acid
unii-tlh4a6lv1w
tlh4a6lv1w ,
4-08-00-02360 (beilstein handbook reference)
FT-0612520
imexine og
lawsone [inci]
q 0
henna (dye)
lawsone [mi]
lawsone [mart.]
SCHEMBL342409
BBL027350
SCHEMBL16541
2-hydroxyl-1,4-naphthoquinone
AC-34621
mfcd00001678
DTXSID2025428
bdbm50049066
J-509606
GS-3117
sr-05000002407
SR-05000002407-1
SY012958
lawsone (2-hydroxy-1,4-naphthoquinone)
27699-93-0
HY-N2493
F17705
2-hydroxy-1,4-naphthaquinone
Q1075492
EN300-20637
AMY7042
CS-0022764
Z104479394
PD006431

Research Excerpts

Overview

Lawsone is a natural naphthoquinone present in the henna leaf extract with several cytotoxic activities. Lawsone is used as precursor for synthesis of various pharmaceutical compounds.

ExcerptReferenceRelevance
"Lawsone is a natural naphthoquinone present in the henna leaf extract with several cytotoxic activities and used as precursor for synthesis of various pharmaceutical compounds. "( Lawsone, a 2-hydroxy-1,4-naphthoquinone from Lawsonia inermis (henna), produces mitochondrial dysfunctions and triggers mitophagy in Saccharomyces cerevisiae.
de Lima Silva, MS; De Morais, MA; Goes, AJS; Queiroz, MG; Santos, MMS; Xavier, MR, 2020
)
3.44
"Lawsone is an active naphthoquinone derivative isolated from henna (Lawsonia inermis L.), a widely used hair dye. "( Cytotoxicity of lawsone and cytoprotective activity of antioxidants in catalase mutant Escherichia coli.
Horita, M; Masuoka, N; Ogino, K; Sano, K; Sauriasari, R; Takemura, Y; Tsutsui, K; Wang, BL; Wang, DH, 2007
)
2.13
"Lawsone is a chemical present in henna, the crushed leaves of which are used worldwide as a cosmetic agent to stain the hair, skin, and nails."( Henna: a potential cause of oxidative hemolysis and neonatal hyperbilirubinemia.
Oski, FA; Zinkham, WH, 1996
)
1.02

Effects

ExcerptReferenceRelevance
"The lawsone content has been evaluated quantitatively in eight commercial henna powders and two collected henna leaves. "( Determination of lawsone in henna powders by high performance thin layer chromatography.
Aboul-Ela, MA; Badr, JM; El-Shaer, NS; Gohar, YM, 2007
)
1.24

Treatment

Lawsone-preconditioned hUMSCs were transplanted into the diabetic rats. Treatment with lawsone to the RIF-INH administered animals significantly lowered the serum transaminases levels.

ExcerptReferenceRelevance
"Untreated and lawsone-preconditioned hUMSCs were transplanted into the diabetic rats via tail vein."( Effect of lawsone-preconditioned mesenchymal stem cells on the regeneration of pancreatic β cells in Type 1 diabetic rats.
Ishaque, A; Kabir, N; Khan, I; Masnoon, J; Salim, A, 2023
)
1.66
"Treatment with lawsone to the RIF-INH administered animals significantly lowered the serum transaminases levels."( Hepatoprotective effect of lawsone on rifampicin-isoniazid induced hepatotoxicity in in vitro and in vivo models.
Al-Dhabi, NA; Balakrishna, K; Darvin, SS; Esakkimuthu, S; Ignacimuthu, S; Pandikumar, P; Paulraj, MG; Toppo, E, 2018
)
1.12

Toxicity

ExcerptReferenceRelevance
" Haemolysis was the only toxic change identified in rats dosed with 2-methyl-1,4-naphthoquinone."( Haemolytic activity and nephrotoxicity of 2-hydroxy-1,4-naphthoquinone in rats.
Fowke, EA; Munday, R; Smith, BL, 1991
)
0.28
" In order to establish if such toxic effects are common to other 2-hydroxynaphthoquinone derivatives, the short-term toxicity of a number of 2-hydroxy-3-alkyl-1,4-naphthoquinones has been compared in rats."( Comparative toxicity of 2-hydroxy-3-alkyl-1,4-naphthoquinones in rats.
Munday, CM; Munday, R; Smith, BL, 1995
)
0.29
" In the present study, rats were dosed with BHA and then challenged with a toxic dose of 2-hydroxy-1,4-naphthoquinone, a substance that causes haemolytic anaemia and renal damage in vivo."( Effect of butylated hydroxyanisole on the toxicity of 2-hydroxy-1,4-naphthoquinone to rats.
Munday, CM; Munday, R; Smith, BL, 1999
)
0.3
"It has previously been shown that rats pre-treated with butylated hydroxyanisole (BHA), a well-known inducer of the enzyme DT-diaphorase, are protected against the toxic effects of 2-methyl-1,4-naphthoquinone but are made more susceptible to the harmful action of 2-hydroxy-1,4-naphthoquinone."( Effect of inducers of DT-diaphorase on the toxicity of 2-methyl- and 2-hydroxy-1,4-naphthoquinone to rats.
Munday, CM; Munday, R; Smith, BL, 1999
)
0.3
" Some such compounds are known, however, to be toxic to both animals and humans."( Structure-activity relationships in the haemolytic activity and nephrotoxicity of derivatives of 1,2- and 1,4-naphthoquinone.
Munday, CM; Munday, R; Smith, BL,
)
0.13
"Temporary henna tattoos have become increasingly popular as a safe alternative to permanent tattoos among American and European children and teenagers during the summer holidays."( Temporary henna tattoo is unsafe in atopic children.
Chianca, M; Chini, L; Corrente, S; Graziani, S; Iannini, R; La Rocca, M; Moschese, V, 2007
)
0.34
" Natural henna leaves did not show toxic effects, whereas two out of four samples of marketed henna products were shown toxicity effects."( Cytotoxicity of lawsone and cytoprotective activity of antioxidants in catalase mutant Escherichia coli.
Horita, M; Masuoka, N; Ogino, K; Sano, K; Sauriasari, R; Takemura, Y; Tsutsui, K; Wang, BL; Wang, DH, 2007
)
0.69

Compound-Compound Interactions

ExcerptReferenceRelevance
" In our research, the effect of naphthazarin (DHNQ) combined with 2-hydroxy-1,4-naphthoquinone (NQ-2-OH) or 1,4-naphthoquinone (1,4-NQ) on the elongation growth, pH changes of the incubation medium, oxidative stress and redox activity of maize coleoptile cells were investigated."( Effects of Naphthazarin (DHNQ) Combined with Lawsone (NQ-2-OH) or 1,4-Naphthoquinone (NQ) on the Auxin-Induced Growth of
Karcz, W; Ludynia, M; Rudnicka, M, 2019
)
0.77

Bioavailability

ExcerptReferenceRelevance
" Atovaquone is a drug that inhibits the respiratory chain of Plasmodium falciparum, but with serious limitations like known resistance, low bioavailability and high plasma protein binding."( Insights into cytochrome bc1 complex binding mode of antimalarial 2-hydroxy-1,4-naphthoquinones through molecular modelling.
Abrahim-Vieira, B; Ferreira, SB; Ferreira, VF; Garcia, CR; Pascutti, PG; Rocha, DR; Silva, FP; Sodero, AC; Torres, PH, 2017
)
0.46
"A structure-activity relationship to evaluate the effect of bioavailability was performed."( Influence of lipophilicity in O-acyl and O-alkyl derivatives of juglone and lawsone: a structure-activity relationship study in the search for natural herbicide models.
Chinchilla, N; Durán, AG; Macías, FA; Molinillo, JM, 2018
)
0.71

Dosage Studied

ExcerptRelevanceReference
" Haemolysis was the only toxic change identified in rats dosed with 2-methyl-1,4-naphthoquinone."( Haemolytic activity and nephrotoxicity of 2-hydroxy-1,4-naphthoquinone in rats.
Fowke, EA; Munday, R; Smith, BL, 1991
)
0.28
" Furthermore, the toxicity of the hydroxy-alkylnaphthoquinones decreased with increasing size of the alkyl substituent and no toxic changes were recorded in animals dosed with 2-hydroxy-3-butyl- or 2-hydroxy-3-pentyl-1,4-naphthoquinone."( Comparative toxicity of 2-hydroxy-3-alkyl-1,4-naphthoquinones in rats.
Munday, CM; Munday, R; Smith, BL, 1995
)
0.29
" In the present study, rats were dosed with BHA and then challenged with a toxic dose of 2-hydroxy-1,4-naphthoquinone, a substance that causes haemolytic anaemia and renal damage in vivo."( Effect of butylated hydroxyanisole on the toxicity of 2-hydroxy-1,4-naphthoquinone to rats.
Munday, CM; Munday, R; Smith, BL, 1999
)
0.3
" Rats were dosed with BHA, butylated hydroxytoluene (BHT), ethoxyquin (EQ), dimethyl fumarate (DMF) or disulfiram (DIS) and then challenged with a toxic dose of the naphthoquinones."( Effect of inducers of DT-diaphorase on the toxicity of 2-methyl- and 2-hydroxy-1,4-naphthoquinone to rats.
Munday, CM; Munday, R; Smith, BL, 1999
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
lawsone biosynthesis02

Protein Targets (37)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency15.81140.140911.194039.8107AID2451
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency28.37090.177814.390939.8107AID2147
phosphopantetheinyl transferaseBacillus subtilisPotency79.43280.141337.9142100.0000AID1490
USP1 protein, partialHomo sapiens (human)Potency50.11870.031637.5844354.8130AID504865
TDP1 proteinHomo sapiens (human)Potency23.10930.000811.382244.6684AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency12.63850.180013.557439.8107AID1460; AID1468
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency27.82980.011212.4002100.0000AID1030
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency28.18380.001815.663839.8107AID894
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency13.34770.354828.065989.1251AID504847
mitogen-activated protein kinase 1Homo sapiens (human)Potency0.03160.039816.784239.8107AID995
DNA polymerase kappa isoform 1Homo sapiens (human)Potency35.48130.031622.3146100.0000AID588579
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency25.11890.031610.279239.8107AID884; AID885
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Dihydroorotate dehydrogenase Schistosoma mansoniIC50 (µMol)29.00000.01901.94088.8000AID1592257
Indoleamine 2,3-dioxygenase 1Homo sapiens (human)IC50 (µMol)675.00000.05373.075710.0000AID326467
Genome polyprotein Human rhinovirus sp.IC50 (µMol)150.00000.00052.98388.2000AID163631
Protease Human immunodeficiency virus 1IC50 (µMol)100.00000.00010.22487.3200AID162196
Integrase Human immunodeficiency virus 1IC50 (µMol)100.00000.00051.544310.0000AID93531; AID93543
Histone-lysine N-methyltransferase SETD7Homo sapiens (human)IC50 (µMol)200.00000.00202.52666.0800AID1667745
Cysteine protease Trypanosoma brucei rhodesienseIC50 (µMol)66.50000.00313.87667.7500AID1754249; AID1754257
Tyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)IC50 (µMol)5.60001.10004.69009.5400AID1182274
P2X purinoceptor 7Mus musculus (house mouse)IC50 (µMol)75.48000.00070.98542.9000AID1401237
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (57)

Processvia Protein(s)Taxonomy
regulation of activated T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of T cell tolerance inductionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of chronic inflammatory responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of type 2 immune responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan catabolic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
inflammatory responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
female pregnancyIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan catabolic process to kynurenineIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
response to lipopolysaccharideIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of interleukin-10 productionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of interleukin-12 productionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
multicellular organismal response to stressIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
kynurenic acid biosynthetic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
swimming behaviorIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of T cell apoptotic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of T cell apoptotic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
'de novo' NAD biosynthetic process from tryptophanIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
DNA damage responseHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
heterochromatin organizationHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
chromatin organizationHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
chromatin remodelingHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
peptidyl-lysine monomethylationHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
peptidyl-lysine dimethylationHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
response to ethanolHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
positive regulation of DNA-templated transcriptionHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
heterochromatin organizationHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
lipid metabolic processTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
autophagyTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
negative regulation of autophagyTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
positive regulation of gene expressionTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
negative regulation of gene expressionTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
T cell differentiationTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
lipopolysaccharide-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
positive regulation of type I interferon productionTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
response to lipopolysaccharideTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
negative regulation of interleukin-6 productionTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
negative regulation of interleukin-8 productionTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
negative regulation of tumor necrosis factor productionTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
positive regulation of type II interferon productionTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
regulation of natural killer cell proliferationTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
positive regulation of toll-like receptor 3 signaling pathwayTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
positive regulation of toll-like receptor 4 signaling pathwayTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
phosphoanandamide dephosphorylationTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
negative regulation of JUN kinase activityTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
regulation of innate immune responseTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
T cell receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
regulation of B cell receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
negative regulation of T cell receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
negative regulation of T cell activationTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathwayTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
cellular response to muramyl dipeptideTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
positive regulation of NLRP3 inflammasome complex assemblyTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
regulation of non-canonical NF-kappaB signal transductionTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
positive regulation of protein K63-linked ubiquitinationTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
negative regulation of p38MAPK cascadeTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (18)

Processvia Protein(s)Taxonomy
electron transfer activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
heme bindingIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
indoleamine 2,3-dioxygenase activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
metal ion bindingIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan 2,3-dioxygenase activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
p53 bindingHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
protein bindingHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
protein-lysine N-methyltransferase activityHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
histone methyltransferase activityHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
histone H3 methyltransferase activityHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
histone H3K4 monomethyltransferase activityHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
chromatin bindingHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
phosphatase activityTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
SH3 domain bindingTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
kinase bindingTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
ubiquitin protein ligase bindingTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (11)

Processvia Protein(s)Taxonomy
cytosolIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
smooth muscle contractile fiberIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
stereocilium bundleIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
cytoplasmIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
nucleoplasmHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
chromosomeHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
nucleolusHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
chromosomeHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
nucleusHistone-lysine N-methyltransferase SETD7Homo sapiens (human)
nucleusTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
cytoplasmic side of plasma membraneTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
perinuclear region of cytoplasmTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
nucleusTyrosine-protein phosphatase non-receptor type 22Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (95)

Assay IDTitleYearJournalArticle
AID566699Inhibition of mushroom tyrosinase at 1 mM after 10 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID1064155Growth inhibition of human A549 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Growth inhibitory activity for cancer cell lines of lapachol and its natural and semi-synthetic derivatives.
AID1754256Inhibition of recombinant Trypanosoma brucei rhodesain at 100 uM using Z-FR-AMC as substrate by fluorimetric analysis
AID1754255Inhibition of recombinant Trypanosoma brucei rhodesain at 100 uM using Z-FR-AMC as substrate by fluorimetric analysis relative to control
AID162196Inhibitory activity against HIV-1 protease1996Journal of medicinal chemistry, Jun-21, Volume: 39, Issue:13
Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
AID566701Inhibition of recombinant anthrax lethal factor at 1 mM after 30 mins by fluorescence assay2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID1667745Inhibition of SET7 (unknown origin) using biotinylated histone polypeptide as substrate in presence of SAM by AlphaLISA assay2020Bioorganic & medicinal chemistry letters, 05-01, Volume: 30, Issue:9
Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitors.
AID349297Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 3.9 ug/ml after 4 hrs by XTT assay relative to control2008European journal of medicinal chemistry, Aug, Volume: 43, Issue:8
Effects of 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid and its ester derivatives on biofilm formation by two oral pathogens, Porphyromonas gingivalis and Streptococcus mutans.
AID349294Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 31.2 ug/ml after 4 hrs by XTT assay relative to control2008European journal of medicinal chemistry, Aug, Volume: 43, Issue:8
Effects of 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid and its ester derivatives on biofilm formation by two oral pathogens, Porphyromonas gingivalis and Streptococcus mutans.
AID566702Inhibition of human recombinant MMP1 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID1182273Inhibition of LYP (unknown origin) incubated for 30 mins at 25 degC before addition of DiFMUP substrate in presence of 5 uM zinc acetate2014Bioorganic & medicinal chemistry letters, Aug-15, Volume: 24, Issue:16
Inhibition of the lymphoid tyrosine phosphatase: the effect of zinc(II) ions and chelating ligand fragments on enzymatic activity.
AID1064152Growth inhibition of human SK-MEL-28 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Growth inhibitory activity for cancer cell lines of lapachol and its natural and semi-synthetic derivatives.
AID1179567Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID152094In vitro antimalarial activity against human malaria parasite, P falciparum (Vietnam Smith strain)1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Synthesis and antimalarial activity of 2-aziridinyl- and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives.
AID117228Tested for acute toxicity which is the single dose given intraperitoneally that will kill one-half of the mice within 5 days1983Journal of medicinal chemistry, Apr, Volume: 26, Issue:4
Substituted 1,4-naphthoquinones vs. the ascitic sarcoma 180 of mice.
AID349292Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 125 ug/ml after 4 hrs by XTT assay relative to control2008European journal of medicinal chemistry, Aug, Volume: 43, Issue:8
Effects of 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid and its ester derivatives on biofilm formation by two oral pathogens, Porphyromonas gingivalis and Streptococcus mutans.
AID566703Inhibition of human recombinant MMP2 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID349296Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 7.8 ug/ml after 4 hrs by XTT assay relative to control2008European journal of medicinal chemistry, Aug, Volume: 43, Issue:8
Effects of 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid and its ester derivatives on biofilm formation by two oral pathogens, Porphyromonas gingivalis and Streptococcus mutans.
AID1592257Inhibition of Schistosoma mansoni DHODH using DHO as substrate measured at 4 secs interval for 60 secs by DCIP reduction based indirect assay2019European journal of medicinal chemistry, Apr-01, Volume: 167Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase.
AID23482Partition coefficient (logP)1983Journal of medicinal chemistry, Apr, Volume: 26, Issue:4
Substituted 1,4-naphthoquinones vs. the ascitic sarcoma 180 of mice.
AID1646860Cytotoxicity against triple-negative human MDA-MB-231 cells assessed as redution in cell viability incubated for 72 hrs by SRB assay2020Bioorganic & medicinal chemistry letters, 01-15, Volume: 30, Issue:2
Synthesis and cytotoxicity evaluation of glycosidic derivatives of lawsone against breast cancer cell lines.
AID117488Maximum survival by an optimum dose at 25 mg/kg in treated to that of untreated mice1983Journal of medicinal chemistry, Apr, Volume: 26, Issue:4
Substituted 1,4-naphthoquinones vs. the ascitic sarcoma 180 of mice.
AID1064153Growth inhibition of human Hs683 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Growth inhibitory activity for cancer cell lines of lapachol and its natural and semi-synthetic derivatives.
AID660266Trypanocidal activity against bloodstream form of Trypanosoma cruzi Y isolated from albino mouse blood after 24 hrs by neubauer chamber analysis2012European journal of medicinal chemistry, Jun, Volume: 52On the search for potential anti-Trypanosoma cruzi drugs: synthesis and biological evaluation of 2-hydroxy-3-methylamino and 1,2,3-triazolic naphthoquinoidal compounds obtained by click chemistry reactions.
AID1403390Cytotoxicity activity against African green monkey Vero cells assessed as reduction in cell viability after 72 hrs by cell-titer-glo assay2018European journal of medicinal chemistry, Jan-20, Volume: 144Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
AID1758987Redox potential of compound in phosphate buffer at pH 7.2 by cyclic voltammetry2021Bioorganic & medicinal chemistry letters, 06-01, Volume: 41Synthesis, biological evaluation, and correlation of cytotoxicity versus redox potential of 1,4-naphthoquinone derivatives.
AID566706Inhibition of human recombinant MMP9 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID349300Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as inhibition of biofilm formation at 31.3 ug/ml after 48 hrs2008European journal of medicinal chemistry, Aug, Volume: 43, Issue:8
Effects of 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid and its ester derivatives on biofilm formation by two oral pathogens, Porphyromonas gingivalis and Streptococcus mutans.
AID349301Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as effect on bacterial growth after 4 hrs by XTT assay relative to control2008European journal of medicinal chemistry, Aug, Volume: 43, Issue:8
Effects of 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid and its ester derivatives on biofilm formation by two oral pathogens, Porphyromonas gingivalis and Streptococcus mutans.
AID1625341Activation of human TRPA1 expressed in HEK293 cells assessed as increase in calcium level at 20 uM by fura2/AM dye based single cell based plate reader analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID21140Solubility in water was determined1983Journal of medicinal chemistry, Apr, Volume: 26, Issue:4
Substituted 1,4-naphthoquinones vs. the ascitic sarcoma 180 of mice.
AID1403393Therapeutic index, ratio of CC50 for African green monkey Vero cells to IC50 for Trypanosoma cruzi Y trypomastigotes infected in monkey LLC-MK2 cells2018European journal of medicinal chemistry, Jan-20, Volume: 144Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1083211Bactericidal activity against Erwinia amylovora 295/93 assessed as growth inhibition in King's B full medium measured at pH 7.2 after overnight incubation by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1182274Inhibition of LYP (unknown origin) using DiFMUP substrate incubated for 2 hrs2014Bioorganic & medicinal chemistry letters, Aug-15, Volume: 24, Issue:16
Inhibition of the lymphoid tyrosine phosphatase: the effect of zinc(II) ions and chelating ligand fragments on enzymatic activity.
AID1754260Reversible inhibition of recombinant Trypanosoma brucei rhodesain using Z-FR-AMC as substrate measured for 30 mins by fluorimetric analysis
AID1646859Cytotoxicity against ER-positive human MCF7 cells assessed as redution in cell viability incubated for 72 hrs by SRB assay2020Bioorganic & medicinal chemistry letters, 01-15, Volume: 30, Issue:2
Synthesis and cytotoxicity evaluation of glycosidic derivatives of lawsone against breast cancer cell lines.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1403391Trypanocidal activity against Trypanosoma cruzi Y trypomastigotes infected in monkey LLC-MK2 cells after 24 hrs by cell-titer-glo assay2018European journal of medicinal chemistry, Jan-20, Volume: 144Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
AID1592258Inhibition of human DHODH using DHO as substrate measured at 4 secs interval for 60 secs by DCIP reduction based indirect assay2019European journal of medicinal chemistry, Apr-01, Volume: 167Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase.
AID1758986Cytotoxicity against human HeLa cells2021Bioorganic & medicinal chemistry letters, 06-01, Volume: 41Synthesis, biological evaluation, and correlation of cytotoxicity versus redox potential of 1,4-naphthoquinone derivatives.
AID1064154Growth inhibition of human U373 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Growth inhibitory activity for cancer cell lines of lapachol and its natural and semi-synthetic derivatives.
AID1059253Inhibition of Wolinella succinogenes quinol/fumarate reductase at 20 uM2013Journal of medicinal chemistry, Dec-12, Volume: 56, Issue:23
Design, synthesis, and biological testing of novel naphthoquinones as substrate-based inhibitors of the quinol/fumarate reductase from Wolinella succinogenes.
AID1403392Trypanocidal activity against infected Swiss Webster mouse derived bloodstream form of Trypanosoma cruzi Y after 24 hrs by cell-titer-glo assay2018European journal of medicinal chemistry, Jan-20, Volume: 144Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
AID349295Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 15.6 ug/ml after 4 hrs by XTT assay relative to control2008European journal of medicinal chemistry, Aug, Volume: 43, Issue:8
Effects of 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid and its ester derivatives on biofilm formation by two oral pathogens, Porphyromonas gingivalis and Streptococcus mutans.
AID326467Inhibition of purified human recombinant IDO2008Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
AID1179573Antifungal activity against fluconazole-resistant Candida albicans by NCCLS method2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID723185Antitrypanosomal activity against Trypanosoma cruzi Y bloodstream trypomastigotes isolated from infected Swiss mouse blood assessed as lysis level after 24 hrs2013European journal of medicinal chemistry, Feb, Volume: 60Synthesis and biological activity against Trypanosoma cruzi of substituted 1,4-naphthoquinones.
AID93531Inhibitory activity against HIV-1 integrase1996Journal of medicinal chemistry, Jun-21, Volume: 39, Issue:13
Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
AID308238Inhibition of pig pancreatic elastase2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
The 1,4-naphthoquinone scaffold in the design of cysteine protease inhibitors.
AID736843Therapeutic index, ratio of cytotoxic TC50 for mouse HT22 cells to neuroprotective PD50 for mouse HT22 cells2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Structure-activity relationship study of vitamin k derivatives yields highly potent neuroprotective agents.
AID566705Inhibition of human recombinant MMP8 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID1179569Antibacterial activity against methicillin-resistant Staphylococcus aureus at 100 ug/well after 24 hrs by well diffusion assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID1754246Inhibition of recombinant Trypanosoma cruzi cruzain at 100 uM using Z-FR-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 mins by fluorimetric analysis relative to control
AID1403406Trypanocidal activity against Trypanosoma cruzi Dm28c intracellular amastigotes infected in African green monkey Vero cells after 72 hrs2018European journal of medicinal chemistry, Jan-20, Volume: 144Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
AID1754248Inhibition of recombinant Trypanosoma brucei rhodesain at 100 uM using Z-FR-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 mins by fluorimetric analysis relative to control
AID155387Inhibitory activity against papain using HPLC assay; Not tested2001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Discovery, total synthesis, HRV 3C-protease inhibitory activity, and structure-activity relationships of 2-methoxystypandrone and its analogues.
AID349291Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 250 ug/ml after 4 hrs by XTT assay relative to control2008European journal of medicinal chemistry, Aug, Volume: 43, Issue:8
Effects of 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid and its ester derivatives on biofilm formation by two oral pathogens, Porphyromonas gingivalis and Streptococcus mutans.
AID736844Neuroprotective activity in mouse HT22 cells assessed as prevention from glutamate-induced oxidative cell death by MTS assay2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Structure-activity relationship study of vitamin k derivatives yields highly potent neuroprotective agents.
AID566704Inhibition of human recombinant MMP3 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID1646858Cytotoxicity against HER2-positive human SKBR3 cells assessed as redution in cell viability incubated for 72 hrs by SRB assay2020Bioorganic & medicinal chemistry letters, 01-15, Volume: 30, Issue:2
Synthesis and cytotoxicity evaluation of glycosidic derivatives of lawsone against breast cancer cell lines.
AID308236Inhibition of papain at 1.3 mM after 20 mins2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
The 1,4-naphthoquinone scaffold in the design of cysteine protease inhibitors.
AID736842Neurotoxicity in mouse HT22 cells assessed as cell viability after 24 hrs by MTS assay2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Structure-activity relationship study of vitamin k derivatives yields highly potent neuroprotective agents.
AID1179571Antifungal activity against fluconazole-resistant Candida albicans at 100 ug/well after 24 hrs by well diffusion assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID1646861Cytotoxicity against human HGF cells assessed as redution in cell viability incubated for 72 hrs by SRB assay2020Bioorganic & medicinal chemistry letters, 01-15, Volume: 30, Issue:2
Synthesis and cytotoxicity evaluation of glycosidic derivatives of lawsone against breast cancer cell lines.
AID1064151Growth inhibition of human PC3 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Growth inhibitory activity for cancer cell lines of lapachol and its natural and semi-synthetic derivatives.
AID1401237Antagonist activity at P2X7R in Swiss Webster mouse peritoneal macrophages assessed as inhibition of ATP-induced propidium iodide uptake preincubated for 10 mins followed by ATP induction measured after 25 mins by fluorescence assay2018European journal of medicinal chemistry, Jan-01, Volume: 1431,4-Naphthoquinones potently inhibiting P2X7 receptor activity.
AID1179572Antibacterial activity against methicillin-resistant Staphylococcus aureus by NCCLS method2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID1594144Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1401236Cytotoxicity against Swiss Webster mouse peritoneal macrophages at 100 uM after 72 hrs by resazurin reduction assay2018European journal of medicinal chemistry, Jan-01, Volume: 1431,4-Naphthoquinones potently inhibiting P2X7 receptor activity.
AID39233Effective dose that would give a 25% increase in the survival time against the ascitic sarcoma 180 in mice1983Journal of medicinal chemistry, Apr, Volume: 26, Issue:4
Substituted 1,4-naphthoquinones vs. the ascitic sarcoma 180 of mice.
AID1403407Therapeutic index, ratio of CC50 for African green monkey Vero cells to IC50 for Trypanosoma cruzi Dm28c intracellular amastigotes infected in African green monkey Vero cells2018European journal of medicinal chemistry, Jan-20, Volume: 144Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
AID1594145Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity 2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1592261Non-competitive inhibition of Schistosoma mansoni DHODH using DHO as substrate measured at 4 secs interval for 60 secs by Lineweaver-Burk plot analysis2019European journal of medicinal chemistry, Apr-01, Volume: 167Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase.
AID93543Inhibitory activity against HIV-1 integrase1996Journal of medicinal chemistry, Jun-21, Volume: 39, Issue:13
Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
AID1592252Inhibition of Schistosoma mansoni DHODH assessed as remaining enzyme activity at 500 uM using DHO as substrate measured at 4 secs interval for 60 secs by DCIP reduction based indirect assay relative to control2019European journal of medicinal chemistry, Apr-01, Volume: 167Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase.
AID1758985Cytotoxicity against human KB cells2021Bioorganic & medicinal chemistry letters, 06-01, Volume: 41Synthesis, biological evaluation, and correlation of cytotoxicity versus redox potential of 1,4-naphthoquinone derivatives.
AID1832330Cytotoxicity against HFF-1 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay2021European journal of medicinal chemistry, Dec-05, Volume: 225Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors.
AID1179568Cytotoxicity against human SAS cells assessed as reduction in cell viability after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID163631Inhibitory activity against HRV 3Cpro using HPLC assay2001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Discovery, total synthesis, HRV 3C-protease inhibitory activity, and structure-activity relationships of 2-methoxystypandrone and its analogues.
AID1403394Therapeutic index, ratio of CC50 for African green monkey Vero cells to IC50 for infected Swiss Webster mouse derived bloodstream form of Trypanosoma cruzi Y2018European journal of medicinal chemistry, Jan-20, Volume: 144Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
AID1754257Inhibition of recombinant Trypanosoma brucei rhodesain using Z-FR-AMC as substrate by fluorimetric analysis relative to control
AID1754249Inhibition of recombinant Trypanosoma brucei rhodesain using Z-FR-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 mins by fluorimetric analysis relative to control
AID1179570Antibacterial activity against Pseudomonas aeruginosa MTCC 201 at 100 ug/well after 24 hrs by well diffusion assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID566700Inhibition of human recombinant 5-lipoxygenase at 1 mM after 10 mins by fluorescence assay2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID1403389Cytotoxicity activity against Swiss Webster mouse primary hepatocytes assessed as reduction in cell viability after 72 hrs by cell-titer-glo assay2018European journal of medicinal chemistry, Jan-20, Volume: 144Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
AID1064150Growth inhibition of human LoVo cells by MTT assay2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Growth inhibitory activity for cancer cell lines of lapachol and its natural and semi-synthetic derivatives.
AID309363Antiinflammatory activity in CD1 mouse assessed as inhibition of croton oil-induced ear oedema at 0.3 umol/cm^2 after 6 hrs2007Bioorganic & medicinal chemistry letters, Oct-15, Volume: 17, Issue:20
Synthesis and anti-inflammatory activity of 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid and its ester derivatives.
AID1059252Inhibition of Wolinella succinogenes succinate/quinone reductase at 20 uM2013Journal of medicinal chemistry, Dec-12, Volume: 56, Issue:23
Design, synthesis, and biological testing of novel naphthoquinones as substrate-based inhibitors of the quinol/fumarate reductase from Wolinella succinogenes.
AID349293Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 62.5 ug/ml after 4 hrs by XTT assay relative to control2008European journal of medicinal chemistry, Aug, Volume: 43, Issue:8
Effects of 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid and its ester derivatives on biofilm formation by two oral pathogens, Porphyromonas gingivalis and Streptococcus mutans.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (390)

TimeframeStudies, This Drug (%)All Drugs %
pre-199025 (6.41)18.7374
1990's26 (6.67)18.2507
2000's128 (32.82)29.6817
2010's157 (40.26)24.3611
2020's54 (13.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.31 (24.57)
Research Supply Index6.06 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index68.60 (26.88)
Search Engine Supply Index2.07 (0.95)

This Compound (43.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (1.19%)5.53%
Reviews19 (4.51%)6.00%
Case Studies138 (32.78%)4.05%
Observational0 (0.00%)0.25%
Other259 (61.52%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]